The 10 Commandments of ESC’s New STEMI Guidelines

The authors have given an entertaining account of the most relevant points and differences between the new STEMI guidelines and the prior ones, from 2014. The article features 10 points resembling the ten commandments, which makes it easy to read, compared to the tedious task of reading the complete guidelines.

1) The emergency systems should help anticipate time from STEMI diagnosis to PCI-mediated reperfusion, to be able to choose the best reperfusion strategy. If ≤ 120 minutes, the patient should be referred directly to PCI; if longer, perform an immediate fibrinolysis (within 10 minutes after diagnosis) and transfer the patient to a PCI center.


Read also: New High Blood Pressure Guidelines”.


2) Cardiac arrest survivors with STEMI on post resuscitation ECG should receive primary PCI.  In cases with no STEMI but still suspected ischemic cause, perform an angiography within 2 hours, after quickly excluding non-coronary causes. 

 

3) Oxygen is recommended only for patients with arterial saturation <90%.

4) Primary PCI includes reperfusion within 90 minutes after diagnosis, using routine transradial approach and routine drug eluting stents (DES). Preload patients with aspirin and prasugrel/ticagrelor and anticoagulation with unfractionated heparin.


Read also: FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI”.


5) Fibrinolysis should be done with a specific fibrin agent, aspirin and clopidogrel and anticoagulation with enoxaparin. In patients ≥75, tenecteplase dose should be adjusted, and loading clopidogrel. Even with successful reperfusion, routine angiography should be prescribed between 2 and 24 hours bolus of lytic.

6) Patients should be monitored at least 24 hours after reperfusion. Early ambulation and discharge are the best option for patients without complications.

7) One year of dual antiplatelet therapy (DAPT: aspirin plus prasugrel or ticagrelor) is the standard. In patients at high risk of bleeding, only 6 months DAPT may be considered, and continue with aspirin. Though controversial, in patients who tolerate one year DAPT presenting high ischemic risk, extending DAPT up to 3 years may be considered.


Read also: DACAB: Ticagrelor and Aspirin Improve Vein Graft Patency”.


8) High doses of statins should be prescribed early when the goal is LDL <70 mg/dl. If not met, additional lipid lowering therapy should be considered.

9) Patients with infarction and normal coronary arteries, commonly called MINOCA, as in Myocardial Infarction With no Obstructive Coronary Atherosclerosis, should receive additional diagnostic studies in order to identify the etiology and adapt therapy, which might differ from the typical STEMI therapy.

10) It is important to establish indicators and audit the clinical practice to improve outcomes in real life patients. This is the only way to reduce the gap between evidence-based recommendations and the daily practice.

Original title: ‘Ten Commandments’ of the 2017 ESC STEMI Guidelines.

Reference: Borja Ibanez y Stefan James. Eur Heart J. Volume 39, Issue 2, 7 January 2018, Pages 83.

30-01-2018-2017-ESC-Guidelines-for-the-management-of-STEMI-patients“]


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...